SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Eva Carola) srt2:(2005-2009)"

Search: WFRF:(Eva Carola) > (2005-2009)

  • Result 1-5 of 5
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Fellström, Bengt, et al. (author)
  • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
  • 2009
  • In: The New England journal of medicine. - 1533-4406 .- 0028-4793. ; 360:14, s. 1395-407
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been proved. METHODS: We conducted an international, multicenter, randomized, double-blind, prospective trial involving 2776 patients, 50 to 80 years of age, who were undergoing maintenance hemodialysis. We randomly assigned patients to receive rosuvastatin, 10 mg daily, or placebo. The combined primary end point was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. Secondary end points included death from all causes and individual cardiac and vascular events. RESULTS: After 3 months, the mean reduction in low-density lipoprotein (LDL) cholesterol levels was 43% in patients receiving rosuvastatin, from a mean baseline level of 100 mg per deciliter (2.6 mmol per liter). During a median follow-up period of 3.8 years, 396 patients in the rosuvastatin group and 408 patients in the placebo group reached the primary end point (9.2 and 9.5 events per 100 patient-years, respectively; hazard ratio for the combined end point in the rosuvastatin group vs. the placebo group, 0.96; 95% confidence interval [CI], 0.84 to 1.11; P=0.59). Rosuvastatin had no effect on individual components of the primary end point. There was also no significant effect on all-cause mortality (13.5 vs. 14.0 events per 100 patient-years; hazard ratio, 0.96; 95% CI, 0.86 to 1.07; P=0.51). CONCLUSIONS: In patients undergoing hemodialysis, the initiation of treatment with rosuvastatin lowered the LDL cholesterol level but had no significant effect on the composite primary end point of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. (ClinicalTrials.gov number, NCT00240331.)
  •  
3.
  •  
4.
  •  
5.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-5 of 5
Type of publication
journal article (2)
book (1)
conference paper (1)
book chapter (1)
Type of content
peer-reviewed (3)
other academic/artistic (2)
Author/Editor
Christensson, Eva (3)
Bohm, Carola (3)
Nilsson, Thomas (2)
MacLeod, Ian (2)
Peacock, Elizabeth E ... (2)
Bergstrand, Thomas (2)
show more...
Gregory, David (2)
Richards, Vicki (2)
Fellström, Bengt (1)
Holdaas, Hallvard (1)
Grönhagen-Riska, Car ... (1)
Jontell, Mats, 1951 (1)
Saalman, Robert, 195 ... (1)
Johnsson, Eva (1)
Zannad, Faiez (1)
Samuelsson, Ola, 195 ... (1)
Lindahl, Karin (1)
Tesar, Vladimir (1)
Wiecek, Andrzej (1)
Mayer, Gert (1)
Björdal, Charlotte, ... (1)
Fjaestad, Monika (1)
Lampel, Katarina (1)
Lundwall, Eva (1)
Sandström, Tom (1)
Schmieder, Roland E. (1)
Parving, Hans Henrik (1)
Jardine, Alan G. (1)
Remuzzi, Giuseppe (1)
Tsakiris, Dimitrios (1)
Sundell, Sten (1)
Gottlow, Mattis, 197 ... (1)
Bannister, Kym (1)
Beutler, Jaap (1)
Chae, Dong-Wan (1)
Chevaile, Alejandro (1)
Cobbe, Stuart M (1)
De Lima, José J (1)
Lins, Robert (1)
McMahon, Alan W (1)
Sonkodi, Sandor (1)
Sci, D (1)
Süleymanlar, Gulteki ... (1)
Todorov, Vasil (1)
Wüthrich, Rudolf P (1)
Kullberg-Lindh, Caro ... (1)
Nyström Godfrey, Ing ... (1)
Gjelstrup Björdal, C ... (1)
Turner-Walker, Gordo ... (1)
Godfrey, Inger Nystr ... (1)
show less...
University
University of Gothenburg (4)
Uppsala University (1)
Swedish National Heritage Board (1)
Language
English (4)
Swedish (1)
Research subject (UKÄ/SCB)
Humanities (3)
Medical and Health Sciences (2)
Natural sciences (1)
Engineering and Technology (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view